EGFR-mutated NSCLC
Oncology
1 drug in development·1 company·0 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| ivonescimab | Summit Therapeutics Inc. (SMMT) |
Deep-dive into EGFR-mutated NSCLC
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis